<ul>
  <li></li>
</ul>
<h2 id="id-202347ExecutiveTeamMeetingNotes-Date">
  Date
</h2>
07 Apr 2023
<h2 id="id-202347ExecutiveTeamMeetingNotes-Attendees">
  Attendees
</h2>
<table>
  <colgroup>
    <col/>
    <col/>
    <col/>
  </colgroup>
  <tbody>
    <tr>
      <th>
        Committee Member
      </th>
      <th>
        Present
      </th>
      <th>
        Absent
      </th>
    </tr>
    <tr>
      <td>
        <a href="https://wiki.nci.nih.gov/display/~kuffelgr" rel="nofollow">
          Kuffel, Gina (NIH/NCI) [C]
        </a>
      </td>
      <td>
        X
      </td>
      <td></td>
    </tr>
    <tr>
      <td>
        <a href="https://wiki.nci.nih.gov/display/~leblancak" rel="nofollow">
          Leblanc, Amy (NIH/NCI) [E]
        </a>
      </td>
      <td>
        X
      </td>
      <td></td>
    </tr>
    <tr>
      <td>
        <a href="https://wiki.nci.nih.gov/display/~jbo" rel="nofollow">
          Otridge, John (NIH/NCI) [C]
        </a>
      </td>
      <td>
        X
      </td>
      <td></td>
    </tr>
    <tr>
      <td>
        <a href="https://wiki.nci.nih.gov/display/~kwone" rel="nofollow">
          Kim, Erika (NIH/NCI) [E]
        </a>
      </td>
      <td>
        X
      </td>
      <td></td>
    </tr>
    <tr>
      <td>
        <a href="https://wiki.nci.nih.gov/display/~sommersc" rel="nofollow">
          Sommers, Connie (NIH/NCI) [E]
        </a>
      </td>
      <td>
        X
      </td>
      <td></td>
    </tr>
    <tr>
      <td>
        Debbie Knapp
      </td>
      <td></td>
      <td>
        X
      </td>
    </tr>
    <tr>
      <td>
        Toby Hecht
      </td>
      <td>
        X
      </td>
      <td></td>
    </tr>
    <tr>
      <td>
        <a href="https://wiki.nci.nih.gov/display/~parchmentr" rel="nofollow">
          Parchment, Ralph (NIH/NCI) [C]
        </a>
      </td>
      <td>
        X
      </td>
      <td></td>
    </tr>
  </tbody>
</table>
<h2 id="id-202347ExecutiveTeamMeetingNotes-Goals">
  Goals
</h2>
<ul>
  <li>
    Discuss updates to ICDC and define emerging strategies and priorities
  </li>
</ul>
<h2 id="id-202347ExecutiveTeamMeetingNotes-SharePointSite">
  SharePoint Site
</h2>
<a href="https://nih.sharepoint.com/sites/NCI-CBIIT-FNL-ICDC-ICDCLeadershipGroups" rel="nofollow">
  https://nih.sharepoint.com/sites/NCI-CBIIT-FNL-ICDC-ICDCLeadershipGroups
</a>
<h2 id="id-202347ExecutiveTeamMeetingNotes-OutstandingActionItems">
  Outstanding Action Items
</h2>
<h2 id="id-202347ExecutiveTeamMeetingNotes-Agenda">
  Agenda
</h2>
<table>
  <colgroup>
    <col/>
    <col/>
    <col/>
  </colgroup>
  <tbody>
    <tr>
      <th>
        Item
      </th>
      <th>
        Who
      </th>
      <th>
        Talking Points
      </th>
    </tr>
    <tr>
      <td>
        The Canine Cancer Registry
      </td>
      <td>
        David White
      </td>
      <td>
        The Take C.H.A.R.G.E. (Canine Health and Registry Exchange)
        <a href="https://gcc02.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.takechargeregistry.com%2F&amp;data=05%7C01%7Cgina.kuffel%40nih.gov%7C961f172f94014a8ede5a08db3773bb92%7C14b77578977342d58507251ca2dc2b06%7C0%7C0%7C638164742457837009%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=hy77Hf12iDK431Sz3I091o8NotwgkHVFqNt8rtMdUag%3D&amp;reserved=0" rel="nofollow">
          www.takechargeregistry.com
        </a>
        is a first-of-its-kind national canine cancer registry that provides the veterinary community, cancer researchers, and dog owners with open access to important canine cancer incidence and prevalence data to help guide diagnosis and treatment decisions.
      </td>
    </tr>
    <tr>
      <td>
        DGAB Updates
      </td>
      <td>
        <a href="https://wiki.nci.nih.gov/display/~kuffelgr" rel="nofollow">
          Kuffel, Gina (NIH/NCI) [C]
        </a>
      </td>
      <td>
        ICDC Studies in Active Submission
        <ul>
          <li>
            ORGANOIDS01
            <ul>
              <li>
                Approved by SAC on 9/22/22
              </li>
              <li>
                “Characterization of healthy and diseased canine tissues and organoids&#34;
              </li>
              <li>
                Iowa State University
              </li>
              <li>
                Status: Submitters generating template-based loading files and uploading to S3 and Sharepoint
              </li>
            </ul>
          </li>
          <li>
            UC01
            <ul>
              <li>
                Approved by SAC on 12/22/22
              </li>
              <li>
                &#34;Whole exome sequencing analysis of canine urothelial carcinomas without BRAF V595E mutation&#34;
              </li>
              <li>
                North Carolina State University
              </li>
              <li>
                36 cases
              </li>
              <li>
                Status: Files received, metadata has been loaded to the dev tier, bucket permissions resolved
              </li>
            </ul>
          </li>
          <li>
            OSA03
            <ul>
              <li>
                Approved by SAC on 4/19/21
              </li>
              <li>
                &#34;Comparative analysis of genome-wide DNA methylation identifies patterns that associate with conserved transcriptional programs in osteosarcoma&#34;
              </li>
              <li>
                University of Minnesota
              </li>
              <li>
                44 cases
              </li>
              <li>
                Status: Template-based loading files generated, object files currently uploading into designated AWS S3 bucket
              </li>
            </ul>
          </li>
        </ul>
      </td>
    </tr>
    <tr>
      <td>
        BPSC Updates
      </td>
      <td>
        <a href="https://wiki.nci.nih.gov/display/~kuffelgr" rel="nofollow">
          Kuffel, Gina (NIH/NCI) [C]
        </a>
      </td>
      <td>
        <ul>
          <li>
            <a href="https://nih.sharepoint.com/:f:/r/sites/NCI-CBIIT-FNL-ICDC-ICDCLeadershipGroups/Shared%20Documents/ICDC%20Leadership%20Groups/ICDC%20Steering%20Committee/BPSC/BPSC%20Working%20Folder/2022%20BPSC%20Review%20Article?csf=1&amp;web=1&amp;e=g8dBHD" rel="nofollow">
              2022 BPSC Review Article
            </a>
            <ul>
              <li>
                Debating whether to go with CR or JNCI
              </li>
              <li>
                The Guidance for CR for a review article would mean that I need to significantly revise the current version…there is a word limit and there is a figure limit (2 tables or figures only).
              </li>
              <li>
                Cheryl London is looking at the JNCI guidance
              </li>
            </ul>
          </li>
        </ul>
      </td>
    </tr>
    <tr>
      <td>
        Upcoming Steering Committee Meeting
      </td>
      <td>
        <a href="https://wiki.nci.nih.gov/display/~parchmentr" rel="nofollow">
          Parchment, Ralph (NIH/NCI) [C]
        </a>
      </td>
      <td>
        <ul>
          <li>
            Thursday April 20, 2023
          </li>
          <li>
            Proposed Agenda:
          </li>
        </ul>
      </td>
    </tr>
  </tbody>
</table>
<h2 id="id-202347ExecutiveTeamMeetingNotes-Minutes(NotVerbatim)">
  Minutes (Not Verbatim)
</h2>
<h2 id="id-202347ExecutiveTeamMeetingNotes-PreviousICDCUseCasesfromSteeringCommittee">
  Previous ICDC Use Cases from Steering Committee
</h2>
1. Genomic correlates across platforms (DNA, RNA, protein).2. Correlating multi-omics data with clinical annotation and phenotypes, particularly outcomes.3. Comparative analyses of canine and human. Examples include:1. Search for conserved mutations between canine and human tumors2. Disease diagnosis (e.g. cancer type) and classification mapping between canines and humans5. Gene expression changes and mutational profiles associated with therapeutic response and outcome6. How do sporadic tumors in non-human mammals compare to sporadic human tumors?7. Correlations and model building from radiomic and pathomic features extracted from medical and histopathologic images with outcomes and genomics, as is currently being widely done with human images8. Develop biomarkers of response and resistance in humans by analyzing the responses and genomic signatures in dogs.
<h2 id="id-202347ExecutiveTeamMeetingNotes-PreviousMeetingMinutes(NotVerbatim)">
  Previous Meeting Minutes (Not Verbatim)
</h2>
TH - Look at drug responses and the tumor itself to determine if there is a biomarker based on genomic expression. In the Intro of the BPSC paper, we could give examples of things that can be done based upon existing drug trial studies. AL - In general, there is such a scarcity of credentialed biology in tumor progression. Drug mechanisms can be highlighted with an imaging reporter. DK - Pre and post biopsies were attempted in Vemurafinib trialAL - Until we have DBs to refer to and a more stable reference genome it is difficult to make progress.Action items